Zafrilla 2 mg, Tabletten

7680685870025 CH-68587 Tabletten

Associated product:

ZAFRILLA cpr 2 mg 6 x 14 pce
Zafrilla 2 mg, Tabletten
Zafrilla 2 mg, Tabletten
Zafrilla 2 mg, Tabletten
1 / 3
google

Article details

Package size
6 x 14
Selling units
84
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/10/2023
Patient information leaflet
Français
23/10/2023
Patient information leaflet
Italien
23/10/2023
Summary of Product Characteristics
Allemand
23/10/2023
Summary of Product Characteristics
Français
23/10/2023
Summary of Product Characteristics
Italien
23/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
62.8 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 126.20
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2023

Authorization holder

Gedeon Richter (Schweiz) AG

1202 Genève

Authorization information

Swissmedic authorization number
68587
Drug name
Zafrilla, Tabletten
Galenic form
FILM
ATC Code
G03DB08
Authorization status
Z
Dispensing category
B
First authorization
05/09/2022
Authorization expiration date
04/09/2027
IT Number
09.99.0.
Domain
Human medicine
Field of application
Behandlung der Endometriose

Package details

Description (FR)
ZAFRILLA cpr 2 mg 6 x 14 pce
Description (DE)
ZAFRILLA Tabl 2 mg 6 x 14 Stk
Market launch
05/09/2022
Narcotic (BTM)
No

Original drug

Visanne, Tabletten
GTIN: 7680601190015
CHF 76.85
View original

Other package sizes (2)

ZAFRILLA cpr 2 mg 2 x 14 pce
2 x 14 TABL
GTIN: 7680685870018
View
None
12 x 14 TABL
GTIN: None
Not in V1